Anthony Carnicelli, MD
Advanced Heart Failure and Transplant Cardiology · Charleston, SCNPI 1376956714
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Abiomed accounts for 62.4% of it on its own, with 6 other manufacturers making up the rest. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in SC, where the typical reported total is $13,902.
Across 42 payments — averaging $133.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$4K
- Medtronic$687
- Abbott$604
- Transmedics, Inc.$439
- Edwards Lifesciences$233
- Cvrx, Inc.$122
- plus $29 from 1 others
What the payments were for
- Travel & lodging$3,00753%
- Food & beverage$2,45344%
- Education$1663%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 24 | $3,511 |
| Medtronic(2 entities) | 7 | $687 |
| Abbott | 6 | $604 |
| Transmedics, Inc. | 1 | $439 |
| Edwards Lifesciences | 2 | $233 |
| Cvrx, Inc. | 1 | $122 |
| Endotronix, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,626 in reported general payments places this provider in the 25th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
See all advanced heart failure and transplant cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 217 | $194,454 |
| JardianceEmpagliflozin | 123 | $103,585 |
| EliquisApixaban | 69 | $64,830 |
| FarxigaDapagliflozin Propanediol | 34 | $33,719 |
| Atovaquone | 13 | $3,097 |
| Metoprolol Succinate | 92 | $1,324 |
| Atorvastatin Calcium | 55 | $635 |
| Spironolactone | 108 | $617 |
| Bumetanide | 18 | $581 |
| Carvedilol | 55 | $491 |
| Amiodarone Hcl | 11 | $384 |
| Hydralazine Hcl | 36 | $280 |
| Ezetimibe | 25 | $265 |
| Furosemide | 61 | $264 |
| Potassium Chloride | 20 | $227 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Charleston
- Ryan TedfordCharleston$528K
- Michael ZileCharleston$358K
- Daniel JudgeCharleston$116K
- Ramsey WehbeCharleston$108K
- Sheldon LitwinCharleston$86K
- Brian HoustonCharleston$43K
- Jan GriffinCharleston$23K
- Adrian VanbakelCharleston$21K
- Daniel SilvermanCharleston$11K
- Vishal RaoCharleston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.